Philadelphia sues Eli Lily, CVS Caremark and others over high insulin costs
4 Articles
4 Articles
Philadelphia sues Eli Lily, CVS Caremark and others over high insulin costs
The City of Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of driving up the cost of insulin. In the lawsuit filed Tuesday, December 23, 2025, the city alleges that the companies engaged in an insulin pricing scheme that inflated the cost of diabetes medications. Named as defendants are pharmacy benefit managers CVS Caremark, Express Scripts, and OptumRx, along with drug man…
Philadelphia Sues PBMs, Drugmakers Over Insulin Prices That Skyrocketed
PHILADELPHIA, PA — The City of Philadelphia has launched a sweeping lawsuit against some of the nation’s largest pharmacy benefit managers and insulin manufacturers, accusing them of orchestrating a pricing scheme that drove the cost of a life-saving drug to staggering heights while misleading the public about efforts to control prices. City officials said the lawsuit, filed last week, targets CVS Caremark, Express Scripts, and OptumRx, along wi…
Philadelphia Joins Insulin Pricing MDL Against Drugmakers, PBMs
Philadelphia on Tuesday filed suit against drug manufacturers Eli Lilly, Novo Nordisk, and Sanofi, along with several pharmacy benefit managers, joining a nationwide multidistrict litigation in New Jersey federal court accusing the companies of unlawfully inflating the price of insulin. The city said its lawsuit is part of the Insulin Pricing Litigation pending in the
The city of Philadelphia sued several administrators and manufacturers of large pharmaceuticals on Tuesday, December 23, 2025, accusing them of inflating insulin prices through a fraudulent reimbursement scheme. According to the lawsuit, companies such as CVS Caremark, Express Scripts, OptumRx, Eli Lilly, Novo Nordisk and Sanofi increased the price of the drug. Although production costs about $2.00, prices have risen from about $20.00 in the 199…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium

